does medicare cover b12 injections vitamin coverage medicare part b b12 injections Medicare Part B Outpatient Coverage medicare cpt code for b12

Subcutaneous injection is the most common research-context format today, but no published human pharmacokinetic study has formally characterized subcutaneous AOD-9604 (this gap was specifically called out in FDA's December 2024 review)

For weight loss, you may need multiple sessions of B12 shots in SoHo

FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List

It usually resolves within 4 to 6 weeks if you ease back on frequency

Treatment strategies for obesity (review including AOD-9604 clinical development)

Outside of that group, published safety data is essentially absent